A new federal law may soon help people taking costly drugs for rheumatologic diseases, some of which may eventually fall subject to Medicare negotiations because of the cost and lack of competition.
The American College of Rheumatology today applauded the passage of key drug pricing reforms in the Inflation Reduction Act that will improve rheumatology patients' access to needed drug therapies and treatments.
Tocilizumab Shortage Continues as Pandemic Wears On medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
email article
WASHINGTON The Centers for Medicare & Medicaid Services (CMS) proposed 2022 Physician Fee Schedule (PFS) rule for Medicare would lower the amount physicians are paid under fee-for-service Medicare and change the requirements for incentives under the Quality Payment Program.
The changes, announced at 8 p.m. Tuesday, include a decrease in the conversion factor the multiplier that Medicare applies to relative value units (RVUs) to calculate reimbursement for a particular service or procedure under Medicare s fee-for-service system. Due to budget neutrality changes required by law and the expiration of a 3.75% payment increase provided by Congress, the proposed CY [calendar year] 2022 PFS conversion factor is $33.58, a decrease of $1.31 from the CY 2021 PFS conversion factor of $34.89, CMS said in a fact sheet. The PFS conversion factor reflects the statutory update of 0.00% and the adjustment necessary to account for changes in relative value units an